For patients with prostate cancer, the Gleason grade represents one of the most important factors in risk stratification and treatment.
1-3 The current Gleason grade group (GG) system involves classification into 1 of 5 prognostic groups (GG1 through GG5, with higher GG indicating greater clinical risk) based on the relative amounts of Gleason patterns (ranging from 3 to 5, with 3 indicating low-grade carcinoma with well-formed glands and 5 indicating undifferentiated, or anaplastic, carcinoma) present. Despite its clinical importance, Gleason grading is highly subjective, with substantial interpathologist variability.
4-9 Although urologic subspecialty–trained pathologists have been reported to have higher rates of concordance with each other as well as higher accuracy than general pathologists with regard to the risk stratification of patients,
10-12 the number of urologic subspecialists is insufficient to review the large volume of prostate biopsies performed each year.